Home › Islet Cell Adenoma › Iowa › Cedar Rapids
Islet Cell Adenoma clinical trials in Cedar Rapids, IA
3 studies for Islet Cell Adenoma are looking for participants at sites in and around Cedar Rapids (within about 30 miles). Open a study to see who can join and how to contact the study team.
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
RecruitingPhase 2
- University of Iowa ( Site 0104), Iowa City · 25 mi away
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
RecruitingPhase 1
- Research Facility, Iowa City · 25 mi away
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
RecruitingPhase 3
- Research Facility, Iowa City · 25 mi away
Islet Cell Adenoma trials in other cities
- Los Angeles, CA5 studies
- Rochester, MN5 studies
- St. Louis, MO5 studies
- Chicago, IL4 studies
- Washington, DC4 studies
- Portland, OR4 studies
- Phoenix, AZ4 studies
- Lexington, KY4 studies
- Salt Lake City, UT4 studies
- Columbus, OH4 studies
- Nashville, TN3 studies
- Baltimore, MD3 studies
Other studies in Cedar Rapids
- Non-Small Cell Lung Cancer20 studies
- Breast Cancer17 studies
- Acute Myeloid Leukemia16 studies
- Cancer (all types)16 studies
- Multiple Myeloma15 studies
- Lung Cancer14 studies
- Colorectal Cancer13 studies
- Prostate Cancer12 studies
- Head and Neck Squamous Cell Carcinoma12 studies
- Melanoma10 studies
- Stroke10 studies
- Endometrial Cancer10 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.